NVIDIA CORPNVIDIA CORP

Institutional investor · Portfolio as of Q1 2026

Top Holdings7 positions

Checking export access…
Activity:

Intel Corp

214.8M$9.5B51.6%$36.90+19.59%
2 qtrssince 2025-Q4
Unchanged
0

Coreweave Inc Cl A

47.2M$3.7B19.9%$56.95+36.02%
5 qtrssince 2025-Q1
Increased
100

Synopsys Inc

4.8M$1.9B10.4%$469.72-15.59%
2 qtrssince 2025-Q4
Unchanged
0

Coherent Corp

7.8M$1.9B10.1%$280.810.00%
1 qtr
New
100
NOKNOK
ADR

Nokia Corp Sponsored Adr

166.4M$1.3B7.3%$6.47+24.27%
2 qtrssince 2025-Q4
Unchanged
0

Nebius Group N V

1.2M$123.5M0.7%$26.92+222.44%
6 qtrssince 2024-Q4
Unchanged
0

GENERATE BIOMEDICINES INC

833,325$10.4M0.1%$12.500.00%
1 qtr
New
41
$18.4B
AUM
7
Positions
Q1 2026
Filing
HI score · 2.0/5
Quarterly 13F Value Change
-30%Q4'24$304.5M+277%Q1'25$1.1B+278%Q2'25$4.3B-11%Q3'25$3.8B+241%Q4'25$13.1B+40%Q1'26$18.4B
Activity profile
$ moved · Q1'26
New49%Increased51%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.7 quarters
<1Q29%1-4Q43%1-2Y29%2Y+0%

NVIDIA CORP manages $18.4B across 7 positions as of Q1 2026. Top holdings: INTC (51.6%), CRWV (19.9%), SNPS (10.4%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2/5.0.

Q1 2026 Summary

Added 2 new positions, increased 1. Top move: CRWV (INCREASED, conviction 100). Portfolio: $18.4B across 7 positions.

Top holdings by portfolio weight

Total AUM$18B
INTC51.58%
CRWV19.91%
SNPS10.40%
COHR10.10%
NOK7.28%
NBIS0.67%
GENB0.06%

Portfolio allocation by GICS sector

Sectors2
Technology99.33%
Communication Services0.67%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L71
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used